The results, presented in Table S5, revealed that 11 patients (29.7%) in the DAB1 methylation group exhibited vascular tumor invasion, compared with 17 patients (60.7%) in the non-methylation group. This evidence concerns the gene DAB1 and vascular neoplasm.